Thyroid Cancer
See also: Thyroid Cancer - clinical resources (31)
Literature Analysis
Mouse over the terms for more detail; many indicate links which you can click for dedicated pages about the topic.
Clicking on the Gene or Topic will take you to a separate more detailed page. Sort this list by clicking on a column heading e.g. 'Gene' or 'Topic'.
Gene | Location | Aliases | Notes | Topic | Papers |
RET | 10q11.21 | PTC, MTC1, HSCR1, MEN2A, MEN2B, RET51, CDHF12, CDHR16, RET-ELE1 | Fusion Translocation | -RET-NTRK1 Rearangements in Papillary Thyroid Cancer -RET-PTC1 Rearangements in Papillary Thyroid Cancer -RET-PTC3 (RET-ELE1) Rearangements in Papillary Thyroid Cancer -t(8,10) RET-HOOK Reaarangements in Papillary Thyroid Cancer -RET mutations in Familial Medullary Thyroid Carcinoma -RET mutations in Multiple Endocrine Neoplasia - type 2A -RET mutations in Multiple Endocrine Neoplasia Type 2b -RET Rearrangements Following Exposure to Ionizing Radiation | 666 |
BRAF | 7q34 | NS7, B-raf, BRAF1, RAFB1, B-RAF1 | -BRAF and Thyroid Cancer | 1055 | |
SLC5A5 | 19p13.11 | NIS, TDH1 | -SLC5A5 and Thyroid Cancer | 283 | |
CCDC6 | 10q21.2 | H4, PTC, TPC, TST1, D10S170 | Fusion | -RET-PTC1 Rearangements in Papillary Thyroid Cancer -CCDC6 and Thyroid Cancer | 239 |
NRAS | 1p13.2 | NS6, CMNS, NCMS, ALPS4, N-ras, NRAS1 | -NRAS and Thyroid Cancer | 216 | |
NCOA4 | 10q11.22 | RFG, ELE1, PTC3, ARA70 | Fusion | -RET-PTC3 (RET-ELE1) Rearangements in Papillary Thyroid Cancer | 164 |
PTEN | 10q23.31 | BZS, DEC, CWS1, GLM2, MHAM, TEP1, MMAC1, PTEN1, 10q23del | -PTEN and Thyroid Cancer | 143 | |
CTNNB1 | 3p22.1 | CTNNB, MRD19, armadillo | -CTNNB1 and Thyroid Cancer | 125 | |
KRAS | 12p12.1 | NS, NS3, CFC2, RALD, KRAS1, KRAS2, RASK2, KI-RAS, C-K-RAS, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, c-Ki-ras2 | -KRAS and Thyroid Cancer | 124 | |
NODAL | 10q22.1 | HTX5 | -NODAL and Thyroid Cancer | 104 | |
HRAS | 11p15.5 | CTLO, HAMSV, HRAS1, RASH1, p21ras, C-H-RAS, H-RASIDX, C-BAS/HAS, C-HA-RAS1 | -HRAS and Thyroid Cancer | 87 | |
CAMP | 3p21.31 | LL37, CAP18, CRAMP, HSD26, CAP-18, FALL39, FALL-39 | -CAMP and Thyroid Cancer | 83 | |
APC | 5q22.2 | GS, DP2, DP3, BTPS2, DP2.5, PPP1R46 | -APC and Thyroid Cancer (FAP Associated) | 63 | |
KIT | 4q12 | PBT, SCFR, C-Kit, CD117 | -KIT and Thyroid Cancer | 52 | |
MEN1 | 11q13.1 | MEAI, SCG2 | -MEN1 and Thyroid Cancer | 47 | |
NTRK1 | 1q23.1 | MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA | Fusion | -RET-NTRK1 Rearangements in Papillary Thyroid Cancer | 46 |
MTOR | 1p36.22 | SKS, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | -MTOR and Thyroid Cancer | 46 | |
TPO | 2p25 | MSA, TPX, TDH2A | -TPO and Thyroid Cancer | 37 | |
NKX2-1 | 14q13.3 | BCH, BHC, NK-2, TEBP, TTF1, NKX2A, NMTC1, T/EBP, TITF1, TTF-1, NKX2.1 | -NKX2-1 and Thyroid Cancer -NKX2-1 (TITF1) and Thyroid Cancer | 20 | |
TERT | 5p15.33 | TP2, TRT, CMM9, EST2, TCS1, hTRT, DKCA2, DKCB4, hEST2, PFBMFT1 | Prognostic | -TERT Promoter Mutations in Thyroid Cancer | 33 |
SLC2A1 | 1p34.2 | CSE, PED, DYT9, GLUT, DYT17, DYT18, EIG12, GLUT1, HTLVR, GLUT-1, SDCHCN, GLUT1DS | -GLUT1 expression in Thyroid Cancers | 31 | |
CDKN1B | 12p13.1 | KIP1, MEN4, CDKN4, MEN1B, P27KIP1 | -CDKN1B and Thyroid Cancer | 31 | |
BIRC5 | 17q25.3 | API4, EPR-1 | -BIRC5 and Thyroid Cancer | 27 | |
TIMP1 | Xp11.3 | EPA, EPO, HCI, CLGI, TIMP, TIMP-1 | -TIMP1 and Thyroid Cancer | 26 | |
PAX8 | 2q13 | Translocation | -PAX8-PPARG fusion in Folicular Thyroid Cancer | 26 | |
PPARG | 3p25.2 | GLM1, CIMT1, NR1C3, PPARG1, PPARG2, PPARgamma | Translocation | -PAX8-PPARG fusion in Folicular Thyroid Cancer | 26 |
GSTM1 | 1p13.3 | MU, H-B, GST1, GTH4, GTM1, MU-1, GSTM1-1, GSTM1a-1a, GSTM1b-1b | -GSTM1 and Thyroid Cancer | 19 | |
GSTT1 | 22q11.23 | -GSTT1 and Thyroid Cancer | 18 | ||
TTF1 | 9q34.13 | TTF-1, TTF-I | -TTF1 and Thyroid Cancer | 17 | |
NOTCH1 | 9q34.3 | hN1, AOS5, TAN1, AOVD1 | -NOTCH1 and Thyroid Cancer | 17 | |
SDHD | 11q23.1 | PGL, CBT1, CWS3, PGL1, QPs3, SDH4, cybS, CII-4 | -SDHD and Thyroid Cancer | 17 | |
TFF3 | 21q22.3 | ITF, P1B, TFI | -TFF3 and Thyroid Cancer | 15 | |
RAP1A | 1p13.2 | RAP1, C21KG, G-22K, KREV1, KREV-1, SMGP21 | -Thyroid Cancer and RAP1A | 14 | |
AKT2 | 19q13.2 | PKBB, PRKBB, HIHGHH, PKBBETA, RAC-BETA | -AKT2 and Thyroid Cancer | 14 | |
HMGA1 | 6p21.31 | HMG-R, HMGIY, HMGA1A | -HMGA1 and Thyroid Cancer | 14 | |
GSTP1 | 11q13.2 | PI, DFN7, GST3, GSTP, FAEES3, HEL-S-22 | -GSTP1 and Thyroid Cancer | 14 | |
PRKAR1A | 17q24.2 | CAR, CNC, CNC1, PKR1, TSE1, ADOHR, PPNAD1, PRKAR1, ACRDYS1 | -PRKAR1A and Thyroid Cancer | 12 | |
GNAS | 20q13.32 | AHO, GSA, GSP, POH, GPSA, NESP, SCG6, SgVI, GNAS1, PITA3, C20orf45 | -GNAS and Thyroid Cancer | 12 | |
TPM3 | 1q21.3 | TM3, TM5, TRK, CFTD, NEM1, TM-5, TM30, CAPM1, TM30nm, TPM3nu, TPMsk3, hscp30, HEL-189, HEL-S-82p, OK/SW-cl.5 | -TPM3 and Thyroid Cancer | 11 | |
TPR | 1q31.1 | -TPR and Thyroid Cancer | 11 | ||
CHEK2 | 22q12.1 | CDS1, CHK2, LFS2, RAD53, hCds1, HuCds1, PP1425 | -CHEK2 and Thyroid Cancer | 11 | |
TERC | 3q26.2 | TR, hTR, TRC3, DKCA1, PFBMFT2, SCARNA19 | -TERC and Thyroid Cancer | 11 | |
ATM | 11q22.3 | AT1, ATA, ATC, ATD, ATE, ATDC, TEL1, TELO1 | -ATM and Thyroid Cancer | 10 | |
MTHFR | 1p36.22 | -MTHFR and Thyroid Cancer | 10 | ||
TGFBR2 | 3p24.1 | AAT3, FAA3, LDS2, MFS2, RIIC, LDS1B, LDS2B, TAAD2, TGFR-2, TGFbeta-RII | -TGFBR2 and Thyroid Cancer | 10 | |
THRB | 3p24.2 | GRTH, PRTH, THR1, ERBA2, NR1A2, THRB1, THRB2, C-ERBA-2, C-ERBA-BETA | -THRB and Thyroid Cancer | 9 | |
CCK | 3p22.1 | -CCK and Thyroid Cancer | 9 | ||
CITED1 | Xq13.1 | MSG1 | -CITED1 and Thyroid Cancer | 9 | |
TRIM27 | 6p22.1 | RFP, RNF76 | -TRIM27 and Thyroid Cancer | 8 | |
AKAP9 | 7q21.2 | LQT11, PRKA9, AKAP-9, CG-NAP, YOTIAO, AKAP350, AKAP450, PPP1R45, HYPERION, MU-RMS-40.16A | -AKAP9 and Thyroid Cancer | 8 | |
IGF1R | 15q26.3 | IGFR, CD221, IGFIR, JTK13 | -IGF1R and Thyroid Cancer | 8 | |
MAPK1 | 22q11.22 | ERK, p38, p40, p41, ERK2, ERT1, ERK-2, MAPK2, PRKM1, PRKM2, P42MAPK, p41mapk, p42-MAPK | -MAPK1 and Thyroid Cancer | 8 | |
HIF1A | 14q23.2 | HIF1, MOP1, PASD8, HIF-1A, bHLHe78, HIF-1alpha, HIF1-ALPHA, HIF-1-alpha | -HIF1A and Thyroid Cancer | 8 | |
AXL | 19q13.2 | ARK, UFO, JTK11, Tyro7 | -AXL Expression in Thyroid Cancer | 7 | |
CALCA | 11p15.2 | CT, KC, PCT, CGRP, CALC1, CGRP1, CGRP-I | -CALCA and Thyroid Cancer | 7 | |
ITGB1 | 10p11.22 | CD29, FNRB, MDF2, VLAB, GPIIA, MSK12, VLA-BETA | -ITGB1 (CD29) and Thyroid Cancer | 7 | |
GFRA1 | 10q25.3 | GDNFR, RET1L, RETL1, TRNR1, GDNFRA, GFR-ALPHA-1 | -GFRA1 and Thyroid Cancer | 7 | |
CAV1 | 7q31.2 | CGL3, PPH3, BSCL3, LCCNS, VIP21, MSTP085 | -CAV1 and Thyroid Cancer | 6 | |
ARAF | Xp11.3 | PKS2, A-RAF, ARAF1, RAFA1 | -ARAF and Thyroid Cancer | 6 | |
DICER1 | 14q32.13 | DCR1, MNG1, Dicer, HERNA, RMSE2, Dicer1e, K12H4.8-LIKE | -DICER1 and Thyroid Cancer | 6 | |
NAT2 | 8p22 | AAC2, PNAT, NAT-2 | -NAT2 and Thyroid Cancer | 6 | |
HHEX | 10q23.33 | HEX, PRH, HMPH, PRHX, HOX11L-PEN | -HHEX and Thyroid Cancer | 5 | |
IGF1 | 12q23.2 | IGFI, IGF-I, IGF1A | -IGF1 Expression in Thyroid Cancer | 5 | |
CD82 | 11p11.2 | R2, 4F9, C33, IA4, ST6, GR15, KAI1, SAR2, TSPAN27 | -CD82 and Thyroid Cancer | 5 | |
PTPRJ | 11p11.2 | DEP1, SCC1, CD148, HPTPeta, R-PTP-ETA | -PTPRJ and Thyroid Cancer | 5 | |
CYP27B1 | 12q14.1 | VDR, CP2B, CYP1, PDDR, VDD1, VDDR, VDDRI, CYP27B, P450c1, CYP1alpha | -CYP27B1 and Thyroid Cancer | 5 | |
TFG | 3q12.2 | TF6, HMSNP, SPG57, TRKT3 | -TFG and Thyroid Cancer | 5 | |
DROSHA | 5p13.3 | RN3, ETOHI2, RNASEN, RANSE3L, RNASE3L, HSA242976 | -DROSHA and Thyroid Cancer | 5 | |
DUSP6 | 12q21.33 | HH19, MKP3, PYST1 | -DUSP6 and Thyroid Cancer | 5 | |
PDGFRA | 4q12 | CD140A, PDGFR2, PDGFR-2 | -PDGFRA and Thyroid Cancer | 5 | |
SERPINA1 | 14q32.13 | PI, A1A, AAT, PI1, A1AT, PRO2275, alpha1AT | -SERPINA1 and Thyroid Cancer | 5 | |
CDK6 | 7q21.2 | MCPH12, PLSTIRE | -CDK6 and Thyroid Cancer | 5 | |
SLC5A8 | 12q23.1-q23.2 | AIT, SMCT, SMCT1 | -SLC5A8 and Thyroid Cancer | 5 | |
HLA-G | 6p22.1 | MHC-G | -HLA-G and Thyroid Cancer | 5 | |
PTPRQ | 12q21.2 | DFNB84, DFNB84A, PTPGMC1, R-PTP-Q | -PTPRQ and Thyroid Cancer | 5 | |
PIGS | 17q11.2 | -PIGS and Thyroid Cancer | 4 | ||
MT1G | 16q13 | MT1, MT1K | -MT1G and Thyroid Cancer | 4 | |
GPC3 | Xq26.2 | SGB, DGSX, MXR7, SDYS, SGBS, OCI-5, SGBS1, GTR2-2 | -GPC3 and Thyroid Cancer | 4 | |
RBP3 | 10q11.22 | IRBP, RBPI, RP66, D10S64, D10S65, D10S66 | -RBP3 and Thyroid Cancer | 4 | |
FAS | 10q23.31 | APT1, CD95, FAS1, APO-1, FASTM, ALPS1A, TNFRSF6 | -FAS and Thyroid Cancer | 4 | |
MAP2K1 | 15q22.31 | CFC3, MEK1, MKK1, MAPKK1, PRKMK1 | -MAP2K1 and Thyroid Cancer | 4 | |
NFKBIA | 14q13.2 | IKBA, MAD-3, NFKBI | -NFKBIA and Thyroid Cancer | 4 | |
RASAL1 | 12q24.13 | RASAL | -RASAL1 and Thyroid Cancer | 4 | |
PITX2 | 4q25 | RS, RGS, ARP1, Brx1, IDG2, IGDS, IHG2, PTX2, RIEG, ASGD4, IGDS2, IRID2, Otlx2, RIEG1 | -PITX2 and Thyroid Cancer | 4 | |
CTGF | 6q23.2 | CCN2, NOV2, HCS24, IGFBP8 | -CTGF and Thyroid Cancer | 4 | |
POLI | 18q21.2 | RAD30B, RAD3OB | -POLI and Thyroid Cancer | 3 | |
ZNF331 | 19q13.42 | RITA, ZNF361, ZNF463 | -ZNF331 and Thyroid Cancer | 3 | |
IKBKB | 8p11.21 | IKK2, IKKB, IMD15, NFKBIKB, IKK-beta | -IKBKB and Thyroid Cancer | 3 | |
AXIN2 | 17q24.1 | AXIL, ODCRCS | -AXIN2 and Thyroid Cancer | 3 | |
CBX7 | 22q13.1 | -CBX7 and Thyroid Cancer | 3 | ||
SSTR5 | 16p13.3 | SS-5-R | -SSTR5 and Thyroid Cancer | 3 | |
THRA | 17q21.1 | AR7, EAR7, ERBA, CHNG6, ERBA1, NR1A1, THRA1, THRA2, ERB-T-1, c-ERBA-1 | -THRA and Thyroid Cancer | 3 | |
PDK1 | 2q31.1 | -PDK1 and Thyroid Cancer | 3 | ||
SDHAF2 | 11q12.2 | PGL2, SDH5, C11orf79 | -SDHAF2 and Thyroid Cancer | 3 | |
CA12 | 15q22.2 | CAXII, CA-XII, T18816, HsT18816 | -CA12 and Thyroid Cancer | 3 | |
BAG3 | 10q26.11 | BIS, MFM6, BAG-3, CAIR-1 | -BAG3 and Thyroid Cancer | 3 | |
AURKB | 17p13.1 | AIK2, AIM1, ARK2, AurB, IPL1, STK5, AIM-1, STK12, PPP1R48, aurkb-sv1, aurkb-sv2 | -AURKB and Thyroid Cancer | 3 | |
PRKCA | 17q24.2 | AAG6, PKCA, PRKACA, PKC-alpha | -PRKCA and Thyroid Cancer | 3 | |
CD63 | 12q13.2 | MLA1, ME491, LAMP-3, OMA81H, TSPAN30 | -CD63 and Thyroid Cancer | 3 | |
SLC34A2 | 4p15.2 | NPTIIb, NAPI-3B, NAPI-IIb | -SLC34A2 and Thyroid Cancer | 3 | |
BUB1 | 2q14 | BUB1A, BUB1L, hBUB1 | -BUB1 and Thyroid Cancer | 3 | |
PRC1 | 15q26.1 | ASE1 | -PRC1 and Thyroid Cancer | 3 | |
G6PD | Xq28 | G6PD1 | -G6PD and Thyroid Cancer | 2 | |
HDAC6 | Xp11.23 | HD6, JM21, CPBHM, PPP1R90 | -HDAC6 and Thyroid Cancer | 2 | |
PIK3CB | 3q22.3 | PI3K, PIK3C1, P110BETA, PI3KBETA | -PIK3CB and Thyroid Cancer | 2 | |
CASP7 | 10q25.3 | MCH3, CMH-1, LICE2, CASP-7, ICE-LAP3 | -CASP7 and Thyroid Cancer | 2 | |
ATG5 | 6q21 | ASP, APG5, APG5L, hAPG5, APG5-LIKE | -ATG5 and Thyroid Cancer | 2 | |
FOXO1 | 13q14.11 | FKH1, FKHR, FOXO1A | -FOXO1 and Thyroid Cancer | 2 | |
MAP3K8 | 10p11.23 | COT, EST, ESTF, TPL2, AURA2, MEKK8, Tpl-2, c-COT | -MAP3K8 and Thyroid Cancer | 2 | |
IMP3 | 15q24.2 | BRMS2, MRPS4, C15orf12 | -IMP3 and Thyroid Cancer | 2 | |
HIPK2 | 7q34 | PRO0593 | -HIPK2 and Thyroid Cancer | 2 | |
PMS2 | 7p22.1 | MLH4, PMSL2, HNPCC4, PMS2CL | -PMS2 and Thyroid Cancer | 2 | |
PTMS | 12p13 | ParaT | -PTMS and Thyroid Cancer | 2 | |
SPRY2 | 13q31.1 | IGAN3, hSPRY2 | -SPRY2 and Thyroid Cancer | 2 | |
MAGEA1 | Xq28 | CT1.1, MAGE1 | -MAGEA1 and Thyroid Cancer | 2 | |
APEX1 | 14q11.2 | APE, APX, APE1, APEN, APEX, HAP1, REF1 | -APEX1 and Thyroid Cancer | 2 | |
CCL5 | 17q12 | SISd, eoCP, SCYA5, RANTES, TCP228, D17S136E, SIS-delta | -CCL5 and Thyroid Cancer | 2 | |
NOTCH4 | 6p21.32 | INT3 | -NOTCH4 and Thyroid Cancer | 2 | |
SSTR1 | 14q21.1 | SS1R, SS1-R, SRIF-2, SS-1-R | -SSTR1 and Thyroid Cancer | 2 | |
OLAH | 10p13 | SAST, AURA1, THEDC1 | -OLAH and Thyroid Cancer | 2 | |
DAPK2 | 15q22.31 | DRP1, DRP-1 | -DAPK2 and Thyroid Cancer | 2 | |
RXRB | 6p21.3 | NR2B2, DAUDI6, RCoR-1, H-2RIIBP | -RXRB and Thyroid Cancer | 2 | |
FGF7 | 15q21.2 | KGF, HBGF-7 | -FGF7 and Thyroid Cancer | 2 | |
KRT20 | 17q21.2 | K20, CD20, CK20, CK-20, KRT21 | -KRT20 and Thyroid Cancer | 2 | |
DLL4 | 15q15.1 | AOS6, hdelta2 | -DLL4 and Thyroid Cancer | 2 | |
PCM1 | 8p22 | PTC4, RET/PCM-1 | -PCM1 and Thyroid Cancer | 2 | |
XRCC6 | 22q13.2 | ML8, KU70, TLAA, CTC75, CTCBF, G22P1 | -XRCC6 and Thyroid Cancer | 2 | |
FTCDNL1 | 2q33.1 | FONG | -FONG and Thyroid Cancer | 2 | |
GPX3 | 5q33.1 | GPx-P, GSHPx-3, GSHPx-P | -GPX3 and Thyroid Cancer | 2 | |
HOOK3 | 8p11.21 | HK3 | Translocation | -t(8,10) RET-HOOK Reaarangements in Papillary Thyroid Cancer | 2 |
RXRG | 1q23.3 | RXRC, NR2B3 | -RXRG and Thyroid Cancer | 2 | |
IGFBP5 | 2q35 | IBP5 | -IGFBP5 and Thyroid Cancer | 2 | |
POT1 | 7q31.33 | GLM9, CMM10, HPOT1 | -POT1 and Thyroid Cancer | 2 | |
CTSL | 9q21.33 | MEP, CATL, CTSL1 | -CTSL1 and Thyroid Cancer | 2 | |
PTGS1 | 9q33.2 | COX1, COX3, PHS1, PCOX1, PES-1, PGHS1, PTGHS, PGG/HS, PGHS-1 | -PTGS1 and Thyroid Cancer | 2 | |
HDAC4 | 2q37.3 | HD4, AHO3, BDMR, HDACA, HA6116, HDAC-4, HDAC-A | -HDAC4 and Thyroid Cancer | 2 | |
CEACAM6 | 19q13.2 | NCA, CEAL, CD66c | -CEACAM6 and Thyroid Cancer | 2 | |
GOLGA5 | 14q32.12 | RFG5, GOLIM5, ret-II | -GOLGA5 and Thyroid Cancer | 2 | |
CDKN1C | 11p15.4 | BWS, WBS, p57, BWCR, KIP2, p57Kip2 | -CDKN1C and Thyroid Cancer | 2 | |
SSTR3 | 22q13.1 | SS3R, SS3-R, SS-3-R, SSR-28 | -SSTR3 and Thyroid Cancer | 2 | |
LTB | 6p21.33 | p33, TNFC, TNFSF3, TNLG1C | -LTB and Thyroid Cancer | 2 | |
KLLN | 10q23.31 | CWS4, KILLIN | -KLLN and Thyroid Cancer | 2 | |
CTSB | 8p23.1 | APPS, CPSB | -CTSB and Thyroid Cancer | 2 | |
EPHB4 | 7q22.1 | HTK, MYK1, HFASD, TYRO11 | -EPHB4 and Thyroid Cancer | 2 | |
PTTG1 | 5q33.3 | EAP1, PTTG, HPTTG, TUTR1 | -PTTG1 and Thyroid Cancer | 2 | |
KAT5 | 11q13.1 | TIP, ESA1, PLIP, TIP60, cPLA2, HTATIP, ZC2HC5, HTATIP1 | -KAT5 and Thyroid Cancer | 2 | |
RAD52 | 12p13.33 | -RAD52 and Thyroid Cancer | 2 | ||
GRASP | 12q13.13 | TAMALIN | -GRASP and Thyroid Cancer | 2 | |
MSH3 | 5q14.1 | DUP, FAP4, MRP1 | -MSH3 and Thyroid Cancer | 2 | |
CAV2 | 7q31.2 | CAV | -CAV2 and Thyroid Cancer | 2 | |
CEACAM7 | 19q13.2 | CGM2 | -CEACAM7 and Thyroid Cancer | 1 | |
ASAH1 | 8p22 | AC, PHP, ASAH, PHP32, ACDase, SMAPME | -ASAH1 and Thyroid Cancer | 1 | |
KTN1 | 14q22.3 | CG1, KNT, MU-RMS-40.19 | -KTN1 and Thyroid Cancer | 1 | |
ST5 | 11p15.4 | HTS1, p126, DENND2B | -ST5 and Thyroid Cancer | 1 | |
PTPRC | 1q31.3-q32.1 | LCA, LY5, B220, CD45, L-CA, T200, CD45R, GP180 | -PTPRC and Thyroid Cancer | 1 | |
HDAC3 | 5q31.3 | HD3, RPD3, RPD3-2 | -HDAC3 and Thyroid Cancer | 1 | |
CASR | 3q13 | CAR, FHH, FIH, HHC, EIG8, HHC1, NSHPT, PCAR1, GPRC2A, HYPOC1 | -CASR and Thyroid Cancer | 1 | |
RASSF2 | 20p13 | CENP-34, RASFADIN | Methylation Epigenetics | -Inactivation of RASSF2 in thyroid cancer | 1 |
IL1A | 2q14 | IL1, IL-1A, IL1F1, IL1-ALPHA | -IL1A and Thyroid Cancer | 1 | |
PYGM | 11q13.1 | -PYGM and Thyroid Cancer | 1 | ||
SPARC | 5q33.1 | ON, OI17, BM-40 | -SPARC and Thyroid Cancer | 1 | |
CD24 | 6q21 | CD24A | -CD24 and Thyroid Cancer | 1 | |
SOX4 | 6p22.3 | EVI16 | -SOX4 and Thyroid Cancer | 1 | |
MAD2L1 | 4q27 | MAD2, HSMAD2 | -MAD2L1 and Thyroid Cancer | 1 | |
IDO1 | 8p11.21 | IDO, INDO, IDO-1 | -IDO1 and Thyroid Cancer | 1 | |
TSPO | 22q13.2 | DBI, IBP, MBR, PBR, PBS, BPBS, BZRP, PKBS, PTBR, mDRC, pk18 | -TSPO and Thyroid Cancer | 1 | |
CARD11 | 7p22.2 | PPBL, BENTA, BIMP3, IMD11, CARMA1 | -CARD11 and Thyroid Cancer | 1 | |
CEACAM3 | 19q13.2 | CEA, CGM1, W264, W282, CD66D | -CEACAM3 and Thyroid Cancer | 1 | |
IL27 | 16p12.1-p11.2 | p28, IL30, IL-27, IL27A, IL-27A, IL27p28 | -IL27 and Thyroid Cancer | 1 | |
ERC1 | 12p13.33 | ELKS, Cast2, ERC-1, RAB6IP2 | -ERC1 and Thyroid Cancer | 1 | |
ITGB2 | 21q22.3 | LAD, CD18, MF17, MFI7, LCAMB, LFA-1, MAC-1 | -ITGB2 and Thyroid Cancer | 1 | |
PTHLH | 12p11.22 | HHM, PLP, BDE2, PTHR, PTHRP | -PTHLH and Thyroid Cancer | 1 | |
CA9 | 9p13.3 | MN, CAIX | -CA9 and Thyroid Cancer | 1 | |
MYCL | 1p34.2 | LMYC, L-Myc, MYCL1, bHLHe38 | -MYCL and Thyroid Cancer | 1 | |
LIG4 | 13q33.3 | LIG4S | -LIG4 and Thyroid Cancer | 1 | |
MYH9 | 22q12.3 | MHA, FTNS, EPSTS, BDPLT6, DFNA17, MATINS, NMMHCA, NMHC-II-A, NMMHC-IIA | -MYH9 and Thyroid Cancer | 1 | |
CEACAM4 | 19q13.2 | NCA, CGM7, CGM7_HUMAN | -CEACAM4 and Thyroid Cancer | 1 | |
IL11 | 19q13.42 | AGIF, IL-11 | -IL11 and Thyroid Cancer | 1 | |
CDK5 | 7q36.1 | LIS7, PSSALRE | -CDK5 and Thyroid Cancer | 1 | |
ABCB1 | 7q21.12 | CLCS, MDR1, P-GP, PGY1, ABC20, CD243, GP170 | -ABCB1 and Thyroid Cancer | 1 | |
MMP13 | 11q22.2 | CLG3, MDST, MANDP1, MMP-13 | -MMP13 and Thyroid Cancer | 1 | |
GAGE1 | Xp11.23 | CT4.1, CT4.4, GAGE4, GAGE-1, GAGE-4 | -GAGE1 and Thyroid Cancer | 1 | |
FOXP1 | 3p13 | MFH, QRF1, 12CC4, hFKH1B, HSPC215 | -FOXP1 and Thyroid Cancer | 1 | |
SIRT3 | 11p15.5 | SIR2L3 | -SIRT3 and Thyroid Cancer | 1 | |
CYP2D6 | 22q13.2 | CPD6, CYP2D, CYP2DL1, CYPIID6, P450C2D, P450DB1, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, P450-DB1 | -CYP2D6 and Thyroid Cancer | 1 | |
GPER1 | 7p22.3 | mER, CEPR, GPER, DRY12, FEG-1, GPR30, LERGU, LyGPR, CMKRL2, LERGU2, GPCR-Br | -GPER1 and Thyroid Cancer | 1 | |
DAPK1 | 9q21.33 | DAPK | -DAPK1 and Thyroid Cancer | 1 | |
C2orf40 | 2q12.2 | ECRG4 | -C2orf40 and Thyroid Cancer | 1 | |
LIMK1 | 7q11.23 | LIMK, LIMK-1 | -LIMK1 and Thyroid Cancer | ||
PTPRH | 19q13.42 | SAP1, R-PTP-H | -PTPRH and Thyroid Cancer | ||
CCKBR | 11p15.4 | GASR, CCK-B, CCK2R | -CCKBR and Thyroid Cancer | ||
CASP9 | 1p36.21 | MCH6, APAF3, APAF-3, PPP1R56, ICE-LAP6 | -CASP9 and Thyroid Cancer |
Note: list is not exhaustive. Number of papers are based on searches of PubMed (click on topic title for arbitrary criteria used).
Selected list of common recurrent structural abnormalities
Abnormality | Type | Gene(s) | |
RET-NTRK1 Rearangements in Papillary Thyroid Cancer | Fusion | RET (10q11.21) | NTRK1 (1q23.1) |
RET-PTC1 Rearangements in Papillary Thyroid Cancer | Fusion | RET (10q11.21) | CCDC6 (10q21.2) |
RET-PTC3 (RET-ELE1) Rearangements in Papillary Thyroid Cancer | Fusion | RET (10q11.21) | NCOA4 (10q11.22) |
t(8,10) RET-HOOK Reaarangements in Papillary Thyroid Cancer | Translocation | RET (10q11.21) | HOOK3 (8p11.21) |
PAX8-PPARG fusion in Folicular Thyroid Cancer | Translocation | PAX8 (2q13) | PPARG (3p25.2) |
This is a highly selective list aiming to capture structural abnormalies which are frequesnt and/or significant in relation to diagnosis, prognosis, and/or characterising specific cancers. For a much more extensive list see the Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer.
Thyroid Carcinoma, Familial Medullary; MTC
OMIM
Disclaimer: This site is for educational purposes only; it can not be used in diagnosis or treatment.
Cite this page: Cotterill SJ. Thyroid Cancer, Cancer Genetics Web: http://www.cancer-genetics.org/X0605.htm Accessed:
This page in Cancer Genetics Web by Simon Cotterill is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Note: content of abstracts copyright of respective publishers - seek permission where appropriate.
[Home] Page last revised: 29 August, 2019 Cancer Genetics Web, Established 1999